An exciting play on the growing market of diagnostic data analytics
This company’s growing data lake of clinical testing data is helping big pharma improve patient testing, leading to better treatment outcomes. Our updated research covers a fascinating business.
Diaceutics (LON:DXRX) is a rapidly growing data analytics and implementation services company supporting many of the world’s largest global pharmaceutical companies. The Group was founded by current CEO, Peter Keeling and Dr Patrick Considine in 2005 and has its headquarters in Belfast, with offices in Dundalk, Ireland, New Jersey in the US and in Singapore. Diaceutics’ services are designed to optimise its pharmaceutical clients’ strategies for the development and launch of precision medicines and specifically, the diagnostic testing required to guide selection of such medicines. Precision medicines/therapies are drugs tailored to individual patient groups dependent on molecular or genetic factors…